Natco Pharma Q3 Results
- BSE: 524816
- NSE: NATCOPHARM
- ISIN: INE987B01026
- Sector: Biotechnology & Drugs
BSE
902.40
-49.85 (-5.23%)
-49.85 (-5.23%)Volume1.75 L
Updated: Fri 14 Aug, 2026 | 15:52:00
NSE
907-44.70 (-4.70%)
-44.70 (-4.70%)Volume2.49 M
Updated: Fri 14 Aug, 2026 | 15:29:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Natco Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 534.80 | 612.60 | -36.04% | 534.70 | 10.72% |
| Depreciation/ Amortization | 46.20 | 45.80 | -11.83% | 44.20 | -1.70% |
| Operating Income | 112.50 | 758.50 | -78.64% | 223.90 | 0.00% |
| Net Income | 151.50 | 677.30 | -70.78% | 212.70 | 13.91% |
| Other Operating Expenses Total | 196.10 | 237.70 | -52.61% | 206.40 | -7.33% |
| Net Income Before Taxes | 161.10 | 818.20 | -73.75% | 256.30 | -1.59% |
| Total Revenue | 647.30 | 1,371.10 | -52.51% | 758.60 | 36.33% |
| Selling/ General/ Admin Expenses Total | 159.40 | 151.50 | -20.42% | 121.90 | 12.57% |
| Diluted Normalized EPS | 8.46 | 37.81 | -70.77% | 11.88 | 13.86% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.